SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-394063
Filing Date
2014-11-03
Accepted
2014-11-03 16:13:36
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d774198d10q.htm 10-Q 278052
2 CERTIFICATION d774198dex311.htm EX-31.1 6269
3 CERTIFICATION d774198dex312.htm EX-31.2 6289
4 CERTIFICATION d774198dex321.htm EX-32.1 2588
5 CERTIFICATION d774198dex322.htm EX-32.2 2576
  Complete submission text file 0001193125-14-394063.txt   2417221

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20140930.xml EX-101.INS 265050
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20140930.xsd EX-101.SCH 33795
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20140930_cal.xml EX-101.CAL 35568
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20140930_def.xml EX-101.DEF 84709
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20140930_lab.xml EX-101.LAB 244057
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20140930_pre.xml EX-101.PRE 157156
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 141189605
SIC: 2834 Pharmaceutical Preparations